Delcath Systems, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: DCTH · Form: DEF 14A · Filed: Apr 12, 2024 · CIK: 872912
Sentiment: neutral
Topics: proxy statement, annual meeting, stockholders, virtual meeting, corporate governance
TL;DR
<b>Delcath Systems, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 23, 2024.</b>
AI Summary
DELCATH SYSTEMS, INC. (DCTH) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. The 2024 Annual Meeting of Stockholders for Delcath Systems, Inc. will be held virtually on May 23, 2024, at 10:00 a.m. Eastern Time. The company is a Delaware corporation. The filing is a Definitive Proxy Statement (DEF 14A). The company's principal executive offices are located at 566 Queensbury Avenue, Queensbury, NY 12804. The filing fee for this document is not required.
Why It Matters
For investors and stakeholders tracking DELCATH SYSTEMS, INC., this filing contains several important signals. This filing provides formal notice to stockholders regarding the upcoming annual meeting, outlining the date, time, and virtual format, which is crucial for shareholder participation in corporate governance. As a DEF 14A filing, it signals that the company is proceeding with its annual shareholder proceedings, which often include voting on board members, executive compensation, and other corporate matters.
Risk Assessment
Risk Level: — DELCATH SYSTEMS, INC. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, containing standard disclosures and no immediate material financial or operational news.
Analyst Insight
Stockholders should review the proxy statement for details on meeting procedures, voting matters, and any proposals to be considered at the annual meeting.
Key Numbers
- 2024 — Annual Meeting Year (2024 Annual Meeting of Stockholders)
- May 23 — Meeting Date (Annual Meeting date)
- 10:00 a.m. ET — Meeting Time (Annual Meeting time)
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Registrant name
- May 23, 2024 (date) — Date of Annual Meeting
- 10:00 a.m. Eastern Time (time) — Time of Annual Meeting
- 566 Queensbury Avenue, Queensbury, NY 12804 (address) — Company business address
- DEF 14A (form_type) — Filing type
FAQ
When did DELCATH SYSTEMS, INC. file this DEF 14A?
DELCATH SYSTEMS, INC. filed this Proxy Statement (DEF 14A) with the SEC on April 12, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by DELCATH SYSTEMS, INC. (DCTH).
Where can I read the original DEF 14A filing from DELCATH SYSTEMS, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by DELCATH SYSTEMS, INC..
What are the key takeaways from DELCATH SYSTEMS, INC.'s DEF 14A?
DELCATH SYSTEMS, INC. filed this DEF 14A on April 12, 2024. Key takeaways: The 2024 Annual Meeting of Stockholders for Delcath Systems, Inc. will be held virtually on May 23, 2024, at 10:00 a.m. Eastern Time.. The company is a Delaware corporation.. The filing is a Definitive Proxy Statement (DEF 14A)..
Is DELCATH SYSTEMS, INC. a risky investment based on this filing?
Based on this DEF 14A, DELCATH SYSTEMS, INC. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting, containing standard disclosures and no immediate material financial or operational news.
What should investors do after reading DELCATH SYSTEMS, INC.'s DEF 14A?
Stockholders should review the proxy statement for details on meeting procedures, voting matters, and any proposals to be considered at the annual meeting. The overall sentiment from this filing is neutral.
How does DELCATH SYSTEMS, INC. compare to its industry peers?
Delcath Systems, Inc. operates in the medical instruments and apparatus industry, focusing on surgical applications.
Are there regulatory concerns for DELCATH SYSTEMS, INC.?
The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.
Industry Context
Delcath Systems, Inc. operates in the medical instruments and apparatus industry, focusing on surgical applications.
Regulatory Implications
The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.
What Investors Should Do
- Review the proxy statement for agenda items and voting procedures for the May 23, 2024 Annual Meeting.
- Confirm virtual meeting access details and any required pre-registration.
- Understand any proposals or director nominations presented for shareholder vote.
Key Dates
- 2024-05-23: Annual Meeting of Stockholders — Key date for shareholder voting and corporate governance decisions.
Year-Over-Year Comparison
This is the initial filing for the 2024 Annual Meeting of Stockholders, following the standard DEF 14A format.
Filing Stats: 4,815 words · 19 min read · ~16 pages · Grade level 13.8 · Accepted 2024-04-12 16:27:45
Key Financial Figures
- $0.01 — 0 the number of shares of common stock, $0.01 par value per share ("Common Stock") av
- $25,439,319 — business on the Record Date, there were $25,439,319 shares of Common Stock outstanding, $9,
- $9,505 — 319 shares of Common Stock outstanding, $9,505 shares of our Series E Preferred Stock
- $1,753 — r Series E Preferred Stock outstanding, $1,753 shares of our Series E-1 Preferred Stoc
- $2,542 — Series E-1 Preferred Stock outstanding, $2,542 shares of our Series F-2 Preferred Stoc
- $3,010 — ies F-2 Preferred Stock outstanding and $3,010 shares of our Series F-3 Preferred Stoc
- $10.00 — k basis, based on a conversion price of $10.00 per share and stated value of $1,000 pe
- $1,000 — of $10.00 per share and stated value of $1,000 per share, subject to the Beneficial Ow
- $4.84 — mmediately preceding March 27, 2023 (or $4.84) and (iii) the average Nasdaq Official
- $4.58 — mmediately preceding March 27, 2023 (or $4.58) (such conversion mechanism, the "Votin
Filing Documents
- dcth-20240412.htm (DEF 14A) — 825KB
- dcth-20240412_g1.jpg (GRAPHIC) — 21KB
- dcth-20240412_g10.jpg (GRAPHIC) — 103KB
- dcth-20240412_g11.jpg (GRAPHIC) — 138KB
- dcth-20240412_g2.jpg (GRAPHIC) — 2KB
- dcth-20240412_g3.jpg (GRAPHIC) — 2KB
- dcth-20240412_g4.jpg (GRAPHIC) — 1KB
- dcth-20240412_g5.jpg (GRAPHIC) — 1KB
- dcth-20240412_g6.jpg (GRAPHIC) — 1KB
- dcth-20240412_g7.jpg (GRAPHIC) — 139KB
- dcth-20240412_g8.jpg (GRAPHIC) — 2KB
- dcth-20240412_g9.jpg (GRAPHIC) — 191KB
- 0001628280-24-016059.txt ( ) — 2897KB
- dcth-20240412.xsd (EX-101.SCH) — 1KB
- dcth-20240412_htm.xml (XML) — 61KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 23 DELINQUENT SECTION 16(A) REPORTS 26 CORPORATE GOVERNANCE AND RELATED MATTERS 27 TRANSACTIONS WITH RELATED PERSONS 32 NON-EMPLOYEE DIRECTOR COMPENSATION 34 INFORMATION ABOUT OUR EXECUTIVE OFFICERS 35
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 36 SUMMARY COMPENSATION TABLE 36 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END —202 3 41 PAY VERSUS PERFORMANCE 42 AUDIT COMMITTEE REPORT 45 STOCKHOLDER PROPOSALS FOR THE 202 5 ANNUAL MEETING 46 HOUSEHOLDING OF PROXY MATERIALS 46 OTHER MATTERS 46 WHERE YOU CAN FIND MORE INFORMATION 47 APPENDIX A: DELCATH SYSTEMS, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN, AS AMENDED A- 1 PROXY CARD 1 Table of Contents 566 Queensbury Avenue, Queensbury, NY 12804 _____________________ PROXY STATEMENT _____________________ INFORMATION ABOUT THE 2024 ANNUAL MEETING AND VOTING The enclosed proxy is solicited by the Board of Directors (the "Board") of Delcath Systems, Inc. ("Delcath," "we," "our," "us" or "the Company") to be voted at our 2024 Annual Meeting of Stockholders (the "Annual Meeting") to be held at 10:00 a.m. Eastern Time on May 23, 2024 in a virtual meeting format only by registering at http://www.viewproxy.com/DCTH/2024/. Registration must be received by 11:59 p.m. Eastern time on May 20, 2024. The Board knows of no matters to come before the Annual Meeting other than those described in this Proxy Statement. If any other matters properly come before the Annual Meeting (or any adjournment thereof), the persons named in the proxy card as proxies will vote on such matters in their discretion in accordance with their best judgement. Matters to be Voted on at the Annual Meeting. At the Annual Meeting, the stockholders of the Company will be asked to consider and take action on the following proposals: (1) to elect Steven Salamon as a Class III director to hold office until the 2027 annual meeting of the Company's stockholders and until their successors are elected and qualified (the "Director Election Proposal"); (2) to approve an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Plan") to increase by 2,000,000 the number of shares of common stock, $0.01 par value per share ("Common Stock") availab